Oral Peptones Load in Normocalcemic and Hypercalcemic Primary Hyperparathyroidism and Healthy Subjects
NCT01042626 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2010-01-05
Summary
The purpose of this study is to assess if subjects with hyperparathyroidism with normal serum calcium levels have different responses in the calcium regulating hormonal handling compared to a) patients with primary hyperparathyroidism and high serum calcium levels; b) healthy subjects.
The differences will be evaluated with oral peptones load and subsequent blood samples collected every 15 minutes for two hours. Ionized calcium, phosphate, gastrin and PTH levels will be evaluated.
Conditions
- Hyperparathyroidism
- Hypercalcemia
Interventions
- OTHER
-
Oral peptones load
Enrolled subjects will receive 10 g Liebig meat extract diluted in 250ml of 0.9% saline
Sponsors & Collaborators
-
University of Milan
collaborator OTHER -
University of Eastern Piedmont
lead OTHER
Study Design
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2004-07-31
- Primary Completion
- 2005-01-31
- Completion
- 2005-01-31
Countries
- Italy
Study Locations
More Related Trials
-
HEXT (Hypo EXTended): Effect of PTH on Skeleton in Hypoparathyroidism
NCT01199614 ·Status: COMPLETED ·Phase: PHASE3
-
Use of NPSP558 in the Treatment of Hypoparathyroidism
NCT00732615 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating Alternative Medical Therapies in Primary Hyperparathyroidism
NCT02525796 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Clinical Study Investigating the Safety, Tolerability, PK and PD of PCO371 in Patients With Hypoparathyroidism
NCT04209179 ·Status: TERMINATED ·Phase: PHASE1
-
A Pilot Study to Assess the Safety and Efficacy of Oral PTH (1-34) in the Treatment of Hypoparathyroidism
NCT02152228 ·Status: COMPLETED ·Phase: PHASE2
-
Diagnostic Performance of [11C]Choline PET/CT In the Preoperative Assessment of Primary Hyperparathyroidism
NCT06647966 ·Status: NOT_YET_RECRUITING
-
Reliability of Serum Calcium to Phosphorus (Ca/P) Ratio as an Accurate and Inexpensive Tool to Define Disorders of Ca-P Metabolism
NCT03603444 ·Status: COMPLETED
-
A Study to Learn if Recombinant Human Parathyroid Hormone [rhPTH(1-84)] Can Improve Symptoms and Metabolic Control in Adults With Hypoparathyroidism (BALANCE)
NCT03324880 ·Status: COMPLETED ·Phase: PHASE4
-
ADD-ON Study to Existing Hypoparathyroidism Studies
NCT00856401 ·Status: UNKNOWN ·Phase: PHASE3
-
3-Week Parathyroid Hormone-related Protein (PTHrP) Dose Escalation Study in Post-Menopausal Women
NCT00222872 ·Status: COMPLETED ·Phase: PHASE1
-
7 Day Continuous Parathyroid Hormone IV Infusion
NCT00377312 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Randomized Study of Human Parathyroid Hormone in Middle-Aged Men With Idiopathic Osteoporosis
NCT00004406 ·Status: COMPLETED ·Phase: NA
-
Comparison Study of PTHrP and PTH to Treat Osteoporosis
NCT00853723 ·Status: COMPLETED ·Phase: PHASE2
-
The Bone-parathyroid Crosstalk in Primary Hyperparathyroidism
NCT05556499 ·Status: NOT_YET_RECRUITING
-
A Phase 3 Randomized Clinical Trial to Investigate the Safety and Efficacy of Palopegteriparatide at Doses Greater Than 30 μg/Day in Adult Participants With Hypoparathyroidism
NCT07081997 ·Status: RECRUITING ·Phase: PHASE3
-
Efficacy, Metabolism and BMD of the 3-month TP Compared to the 1-month TP in ICPP
NCT06487143 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Effects of a Liquid Meal and Gut Hormones (GIP and GLP-2) on Bone Remodeling in Participants With Hypoparathyroidism.
NCT03728959 ·Status: COMPLETED ·Phase: NA
-
Frequency of Hyperparathyroidism in Postmenopausal Osteoporosis and Its Treatment
NCT05347082 ·Status: COMPLETED ·Phase: NA
-
Effect of CTAP101 Capsules on Ca/iPTH in Advanced Breast/Prostate Cancer Patients Treated With Denosumab/Zoledronic Acid
NCT02274623 ·Status: COMPLETED ·Phase: PHASE1
-
Osteoporosis in Primary Hyperparathyroidism
NCT04085419 ·Status: UNKNOWN ·Phase: PHASE4
-
Once Weekly Parathyroid Hormone for Osteoporosis
NCT00065637 ·Status: COMPLETED ·Phase: PHASE3
-
Institution of an Italian Multicenter Database of Patients Affected by Hypoparathyroidism or Pseudohypoparathyroidism
NCT06645899 ·Status: RECRUITING
-
Primary Hyperparathyroidism: Does a Systematic Treatment Improve the Calcium and Bone Metabolism After Surgery?
NCT00973336 ·Status: UNKNOWN ·Phase: PHASE2
-
Treatment of Primary Hyperparathyroidism With Denosumab and Cinacalcet.
NCT03027557 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Adynamic Bone Disorder With Parathyroid Hormone in Chronic Kidney Disease
NCT04522622 ·Status: RECRUITING ·Phase: PHASE4